Cumberland Pharmaceuticals Inc.
209 10th Avenue
Suite 332
Nashville
Tennessee
37203
United States
Tel: 615-255-0068
Fax: 615-255-0094
Website: http://www.cumberlandpharma.com/
Email: mail@cumberlandpharma.com
254 articles about Cumberland Pharmaceuticals Inc.
-
Cumberland Pharmaceuticals Raises $85 Million IPO, First Pharma IPO in Nearly Two Years
8/12/2009
-
Cumberland Pharmaceuticals Announces FDA Approval of Caldolor(TM)
6/12/2009
-
Cumberland Pharmaceuticals Appoints Lee as Product Director
1/14/2009
-
Cumberland Pharmaceuticals Reports FDA Approval for Updated Labeling of Acetadote(R)
12/19/2008
-
Cumberland Pharmaceuticals Taps Industry Veteran for Key Executive Position
9/4/2008
-
Cumberland Pharmaceuticals Announces Appointments
12/19/2007
-
Cumberland Pharmaceuticals Announces Senior Management Promotions
11/12/2007
-
Cumberland Pharmaceuticals Sets 6.25 Million Share IPO
7/24/2007
-
Cumberland Pharmaceuticals Files for $115 Million IPO
5/2/2007
-
Cumberland Pharmaceuticals Offers Alternative to Zelnorm(R)
4/25/2007
-
Cumberland Pharmaceuticals Acquires Hospital Sales Force
1/18/2007
-
Cumberland Pharmaceuticals Announces New Kristalose(R) Agreement
9/12/2006
-
The University of Tennessee Research Foundation And Cumberland Emerging Technologies Announce Collaboration Agreement
5/15/2006
-
Cumberland Pharmaceuticals Announces Updated Labeling For Acetadote(R)
3/6/2006